1. Home
  2. ABCL vs SCHL Comparison

ABCL vs SCHL Comparison

Compare ABCL & SCHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABCL
  • SCHL
  • Stock Information
  • Founded
  • ABCL 2012
  • SCHL 1920
  • Country
  • ABCL Canada
  • SCHL United States
  • Employees
  • ABCL N/A
  • SCHL N/A
  • Industry
  • ABCL Biotechnology: Pharmaceutical Preparations
  • SCHL Books
  • Sector
  • ABCL Health Care
  • SCHL Consumer Discretionary
  • Exchange
  • ABCL Nasdaq
  • SCHL Nasdaq
  • Market Cap
  • ABCL 895.0M
  • SCHL 838.6M
  • IPO Year
  • ABCL 2020
  • SCHL 1987
  • Fundamental
  • Price
  • ABCL $2.69
  • SCHL $25.68
  • Analyst Decision
  • ABCL Buy
  • SCHL
  • Analyst Count
  • ABCL 3
  • SCHL 0
  • Target Price
  • ABCL $8.50
  • SCHL N/A
  • AVG Volume (30 Days)
  • ABCL 2.4M
  • SCHL 204.9K
  • Earning Date
  • ABCL 11-04-2024
  • SCHL 12-19-2024
  • Dividend Yield
  • ABCL N/A
  • SCHL 3.22%
  • EPS Growth
  • ABCL N/A
  • SCHL N/A
  • EPS
  • ABCL N/A
  • SCHL 0.81
  • Revenue
  • ABCL $32,962,000.00
  • SCHL $1,598,400,000.00
  • Revenue This Year
  • ABCL N/A
  • SCHL $6.25
  • Revenue Next Year
  • ABCL $36.56
  • SCHL $4.85
  • P/E Ratio
  • ABCL N/A
  • SCHL $30.74
  • Revenue Growth
  • ABCL N/A
  • SCHL N/A
  • 52 Week Low
  • ABCL $2.34
  • SCHL $23.69
  • 52 Week High
  • ABCL $6.06
  • SCHL $40.74
  • Technical
  • Relative Strength Index (RSI)
  • ABCL 42.74
  • SCHL 41.88
  • Support Level
  • ABCL $2.76
  • SCHL $25.22
  • Resistance Level
  • ABCL $3.05
  • SCHL $26.05
  • Average True Range (ATR)
  • ABCL 0.17
  • SCHL 0.78
  • MACD
  • ABCL -0.03
  • SCHL -0.11
  • Stochastic Oscillator
  • ABCL 6.98
  • SCHL 0.63

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company have extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

About SCHL Scholastic Corporation

Scholastic Corp is an American publishing and education media company that focuses on books and educational material for schools, teachers, parents, and children. It creates print, digital, and audiobooks, learning materials and programs, classroom magazines, and other products that support children's learning and reading both at home and at school. The company also owns rights to various books, including Harry Potter, Dog Man, and The Hunger Games among others. It has three reportable segments Children's Book Publishing and Distribution, Education Solutions, and International. The majority of its revenue is from the Children's Book Publishing and Distribution segment.

Share on Social Networks: